Styla Pharmaceutical Private Limited
About Styla Pharmaceutical Private Limited
Data last updated:
Styla Pharmaceutical Private Limited is a private limited company based in Chandigarh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 24 November 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24230CH2020PTC043353. Its GSTIN is 04ABECS9593A1ZA (Chandigarh). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors including Paraspreet Singh and Gaurav Sardana.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No. 2236/1 & 2236/2 2nd Floor, Pipli Wala Town, Chandigarh, India – 160101.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.54 Cr, a growth of 40% compared to the previous year. For the same year it recorded a net profit of ₹1.27 Lakh (net margin 0.8%) and EBITDA of ₹1.76 Lakh (EBITDA margin 1.1%).
As per MCA filings, the company has open charges of ₹50 Lakh on record.
Company details
Contact details
Styla Pharmaceutical Private Limited's registered office is in Chandigarh, Chandigarh. Its e-mail address is in the company report.
- Email
- Registered AddressShop No. 2236/1 & 2236/2 2nd Floor, Pipli Wala Town, Chandigarh, India – 160101
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Styla Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Styla Pharmaceutical is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Styla Pharmaceutical Private Limited, buy the company report.
Financials of Styla Pharmaceutical Private Limited
FY 2025 filings availableStyla Pharmaceutical Private Limited reported revenue of ₹1.54 Cr (up 40% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 40% in the latest year. EBITDA rose 43% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹1.76 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹1.27 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 1.1% | |||
| Net Profit Margin | 0.8% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Styla Pharmaceutical Private Limited, buy the company report.
Board of directors of Styla Pharmaceutical Private Limited
Styla Pharmaceutical has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Paraspreet Singh | Director | 18 May 2023 | 3 Years 5 Months | Current |
| Gaurav Sardana Also directs: Zpax International Limited | Director | 11 Nov 2024 | 1 Years 11 Months | Current |
| Sukhwinder Kaur | Director | 24 Nov 2020 | 5 Years 11 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 04 Feb 2025 | 101049404 | Canara Bank | ₹50 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Styla Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Styla Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Styla Pharmaceutical Private Limited has 1 active EPFO establishment as of Apr 05, 2024.
GST
Styla Pharmaceutical has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 04ABECS9593A1ZA | Chandigarh | Active | 05 Jan 2021 |
To see the full GST registrations and return filing status of Styla Pharmaceutical Private Limited, buy the company report.
Recent activity
Styla Pharmaceutical Private Limited has 4 board changes on record since 2020: 3 appointments and 1 cessation. The latest: Gaurav Sardana was appointed as Director on 11 Nov 2024.
Frequently asked questions
Styla Pharmaceutical is an active private limited company based in Chandigarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 24 November 2020 (6+ years old) and is registered under CIN U24230CH2020PTC043353.
Styla Pharmaceutical has 3 current directors:
- Paraspreet Singh - Director
- Gaurav Sardana - Director
- Sukhwinder Kaur - Director
The latest financial statements of Styla Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Styla Pharmaceutical is 04ABECS9593A1ZA, registered in Chandigarh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Styla Pharmaceutical is U24230CH2020PTC043353. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Styla Pharmaceutical was incorporated on 24 November 2020, making it 6+ years old. It is registered with the Registrar of Companies, Chandigarh.
Gaurav Sardana was appointed as Director on 11 Nov 2024. Paraspreet Singh was appointed as Director on 18 May 2023. Smriti Biswas ceased to be Director on 17 May 2023. Styla Pharmaceutical has 4 board changes on record in total.
The registered office of Styla Pharmaceutical is at Shop No. 22361 & 22362 2nd Floor, Pipli Wala Town, Chandigarh, India – 160101.
Styla Pharmaceutical operates in the pharma industry, in the drug formulation and development segment.
Styla Pharmaceutical has open charges of ₹50 Lakh and no satisfied charges on record as per latest MCA filings.